Pulmozyme

In the US, Pulmozyme (dornase alfa systemic) is a member of the drug class miscellaneous respiratory agents and is used to treat Cystic Fibrosis.

US matches:

• Pulmozyme


• Pulmozyme inhalation

UK matches:

• Pulmozyme 2500 U/ 2.5ml, nebuliser solution (SPC)

Ingredient matches for Pulmozyme

Deoxyribonuclease I

Deoxyribonuclease I Dornase alfa (a derivative of Deoxyribonuclease I) is reported as an ingredient of Pulmozyme in the following countries:

• Argentina


• Australia


• Austria


• Belgium


• Bosnia & Herzegowina


• Brazil


• Canada


• Chile


• Colombia


• Croatia (Hrvatska)


• Cyprus


• Czech Republic


• Denmark


• Estonia


• Finland


• France


• Germany


• Greece


• Hungary


• Iceland


• Ireland


• Israel


• Italy


• Latvia


• Lebanon


• Lithuania


• Luxembourg


• Malta


• Mexico


• Netherlands


• New Zealand


• Norway


• Oman


• Peru


• Poland


• Portugal


• Romania


• Russian Federation


• Saudi Arabia


• Serbia


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Turkey


• United Kingdom


• United States


• Uruguay

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.